Latest news with #OliviaBrown
Forbes
21-05-2025
- Forbes
Warning — Automated Instagram And TikTok Hack Attacks Confirmed
Instagram and TikTok accounts are under attack from automated hackers. If there are two things that criminal wannabe hackers like, it's making money and doing so by the easiest route possible. Unlike real hackers, the type who use true skill to uncover zero-day vulnerabilities and make the world a safer place, while still earning big money, criminals are lazy by nature and often not highly-skilled either. So, when they can use automated tools and pre-compiled lists of stolen usernames and passwords, they are not only happy but dangerous. Which is why the discovery of a trio of such tools, used in Instagram and TikTok hack attacks, is of concern. Here's what you need to know. Your data has already been stolen. There, I said it, and now it's time to admit that it's true. I don't know of anyone, personally, whose email address does not appear in at least one dark web data breach report, who hasn't had a password appear in a compromised credentials combo list. I mean, it's not beyond the realm of possibility that you, dear reader, are the golden child whose data remains untouched, but it is unlikely. Why am I telling you what you already know? To reiterate the importance of that leaked data to the criminal hacker. Especially, of course, account authentication credentials such as usernames, passwords and email addresses. Olivia Brown, a threat analyst at Socket Security, has published a report that confirms just how important securing your data is by revealing the consequences of that leaked data being out there. 'Obtaining valid credentials, even just emails, can initiate an exploit chain,' Brown warned, explaining that attackers look to ensure emails they have are properly associated with accounts in order to best target their exploit endeavors. The Socket researchers found a trio of what are known as 'checkers' being used to validate stolen email addresses during Instagram and TikTok hack attacks. 'Checkers are automated tools, either scripts or software,' Brown said, 'used to validate large volumes of stolen usernames or emails.' The attackers employ these to automatically and systematically test the compromised credentials they have purchased against the login interfaces of websites or mobile applications, as well as application programming interfaces, to quickly and effectively identify accounts which are valid and therefore vulnerable. Explaining how one of the checkers in question targeted TikTok, Brown said that it checks if an email is registered by abusing the internal TikTok API endpoint. This URL is hardcoded to the private password recovery API, and as such is 'intended to allow a legitimate user to request a password reset link for their account by providing their email address,' Brown said. The attacker, however, uses the checker to mimic a legitimate TikTok client with fake device identifiers and session cookies. It uses a TikTok Android client user-agent to avoid being caught by TikTok's anti-bot protections, and looks for all intents and purposes like a genuine password reset form submitted by TikTok. Brown reported the three malicious Instagram and TikTok hack checkers that Socket discovered to the Python Package Index security team, and they have now been removed. They were: checker-SaGaF, steinlurks and sinnercore. I have reached out to Instagram and TikTok for advice to provide to users.
Forbes
03-05-2025
- Forbes
Data-Stealing Gmail Tunnel Created By Hackers — What You Need To Know
Beware this Python threat that creates a Gmail tunnel. Love it or loathe it, you can't ignore Google's highly popular free email platform, Gmail. With reports of sophisticated threats against users and seven-day account recovery warnings following password compromises, this is one email service that's never far from the news headlines. While many of these involve direct attacks against Gmail accounts, some are a little more, shall we say, complex in terms of the threat they pose. Such is the case with the latest report from security researchers who have uncovered Coffin-Code attackers using malicious Python packages designed to create a data-exfiltrating tunnel by way of Gmail. Here's what you need to know. Let's start at the beginning and make it clear that the Simple Mail Transfer Protocol at the heart of this attack mechanism is not used by Gmail alone. SMTP is the de facto communication protocol used to send and receive email across the internet. It is, however, a highly trusted protocol just as Gmail is a highly trusted email provider. Trust plus trust, in this case, equals danger. What the Socket Threat Research Team discovered, as reported by Olivia Brown, a threat analyst at Socket, is that attackers have created a bunch of malicious Python packages that use Gmail's SMTP protocol to create a tunnel that can exfiltrate data and execute attack commands. Read the full report if you want all the technical details. Although all seven malicious packages have now been removed from the Python Package Index, the attack methodology is worth taking note of. 'Watch for unusual outbound connections, especially SMTP traffic, since attackers can use legitimate services like Gmail to steal sensitive data,' Brown warned. I have reached out to Gmail for a statement.
Yahoo
12-03-2025
- Business
- Yahoo
Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
PARIS, FRANCE, March 12th, 2025 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven company, announced today the appointment of Olivia Brown as, EVP, Global Head of Neurotoxins, effective April 1st, 2025. She will serve on Ipsen's Executive Leadership Team (ELT) and report directly to Chief Executive Officer David Loew. In this newly created role, she will lead Ipsen's global neurotoxins franchise, overseeing strategy and execution across both therapeutic and aesthetic indications. Over the last 30 years in the neurotoxins market, Ipsen has established itself as one of the leading players in neurosciences, successfully driving research, clinical development and growth based on significant manufacturing know-how and capacity. "We are delighted to welcome Olivia to Ipsen's Executive Leadership Team. With her deep expertise in neurotoxins, combined with her experience in global strategy and commercialization, she will be instrumental in further accelerating our growth and innovation in neurotoxins, both in the therapeutic and aesthetic space," said David Loew, CEO, Ipsen. 'With a robust portfolio of products and an attractive pipeline including the potential break-through innovation of the recombinant Long-Acting Neuro-Toxine (LANT) program, it is the right time for us to create an integrated franchise. The long acting neurotoxin was uniquely designed to bind to the receptors used by the BoNT B and to deliver the active light chain of the BoNT A, demonstrating in preclinical studies a longer duration of action and less tissue spread compared to currently available BoNT As. We believe LANT AB has the potential ability to deliver better outcomes for patients with an increased duration of action, leading to a potential reduction in injection frequency and enhanced tolerability.' Olivia brings over 20 years of global leadership experience in pharmaceuticals and medical aesthetics, with a strong track record in business transformation, market expansion, and product launches. Most recently, she was at Novartis, where she led the establishment of a new therapeutic area in Allergy & Immunology. Previously, she held senior leadership positions at Merz Aesthetics and Galderma, where she played a key role in expanding the global neurotoxins market."I am excited to join Ipsen at such an important time for its neurotoxins business. Ipsen has a strong foundation in innovation, and I look forward to working with the team to build on this success and drive further growth in this dynamic market,' said Olivia Brown. This appointment reflects Ipsen's continued investment in neurotoxin innovation, global expansion, and leadership in both therapeutic and aesthetic indications. * botulinum toxin type B (BoNT-B) ** botulinum toxin type A (BoNT-A) About Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 80 countries. Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information, visit Ipsen contacts Investors Alina LEVCHUK | + 41 79 572 8712 | Nicolas BOGLER | + 33 6 52 19 98 92 | Media Sally BAIN | + 1 857 320 0517 | Anne LIONTAS | + 33 7 67 34 72 96 | Disclaimers and/or Forward-Looking StatementsThe forward-looking statements, objectives and targets contained herein are based on Ipsen's management strategy, current views and assumptions. Such statements involve known and unknown risks and uncertainties that may cause actual results, performance or events to differ materially from those anticipated herein. All of the above risks could affect Ipsen's future ability to achieve its financial targets, which were set assuming reasonable macroeconomic conditions based on the information available today. Use of the words 'believes', 'anticipates' and 'expects' and similar expressions are intended to identify forward-looking statements, including Ipsen's expectations regarding future events, including regulatory filings and determinations. Moreover, the targets described in this document were prepared without taking into account external-growth assumptions and potential future acquisitions, which may alter these parameters. These objectives are based on data and assumptions regarded as reasonable by Ipsen. These targets depend on conditions or facts likely to happen in the future, and not exclusively on historical data. Actual results may depart significantly from these targets given the occurrence of certain risks and uncertainties, notably the fact that a promising medicine in early development phase or clinical trial may end up never being launched on the market or reaching its commercial targets, notably for regulatory or competition reasons. Ipsen must face or might face competition from generic medicine that might translate into a loss of market share. Furthermore, the research and development process involves several stages each of which involves the substantial risk that Ipsen may fail to achieve its objectives and be forced to abandon its efforts with regards to a medicine in which it has invested significant sums. Therefore, Ipsen cannot be certain that favorable results obtained during preclinical trials will be confirmed subsequently during clinical trials, or that the results of clinical trials will be sufficient to demonstrate the safe and effective nature of the medicine concerned. There can be no guarantees a medicine will receive the necessary regulatory approvals or that the medicine will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Other risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation; global trends toward healthcare cost containment; technological advances, new medicine and patents attained by competitors; challenges inherent in new-medicine development, including obtaining regulatory approval; Ipsen's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of Ipsen's patents and other protections for innovative medicines; and the exposure to litigation, including patent litigation, and/or regulatory actions. Ipsen also depends on third parties to develop and market some of its medicines which could potentially generate substantial royalties; these partners could behave in such ways which could cause damage to Ipsen's activities and financial results. Ipsen cannot be certain that its partners will fulfil their obligations. It might be unable to obtain any benefit from those agreements. A default by any of Ipsen's partners could generate lower revenues than expected. Such situations could have a negative impact on Ipsen's business, financial position or performance. Ipsen expressly disclaims any obligation or undertaking to update or revise any forward looking statements, targets or estimates contained in this press release to reflect any change in events, conditions, assumptions or circumstances on which any such statements are based, unless so required by applicable law. Ipsen's business is subject to the risk factors outlined in its registration documents filed with the French Autorité des Marchés Financiers. The risks and uncertainties set out are not exhaustive and the reader is advised to refer to Ipsen's latest Universal Registration Document, available on Attachment PR_ELT Announcement_13032025Sign in to access your portfolio
Associated Press
29-01-2025
- Entertainment
- Associated Press
Exclusive Media Rides on the Original Miami Vice #1 Filming Boat (Driven On Screen by Don Johnson) in honor of the 40th Anniversary of the Iconic TV series
Step aboard a cultural icon that defined 1980s cool. The 'Miami Vice' Wellcraft 38KV Scarab MIAMI, FL / ACCESS Newswire / January 29, 2025 / The stage is set for an unforgettable day as Iconic Premier extends a special invitation to all accredited media professionals. In celebration of the 40th anniversary of Miami Vice, the original #1 filming boat that became a global symbol of glamour and adventure will host free media rides on the waterways of Key Biscayne. This is a unique chance for media outlets to step into a landmark of television history and create captivating stories for their audiences. Special Guest Appearance Olivia Brown, famously known as Trudy from Miami Vice, will be joining the event. Her presence adds a nostalgic connection for fans of the show, making this celebration even more special. Event Details Date: February 11, 2025 Time: 9 AM to dusk Location: Crandon Park Marina, 4000 Crandon Blvd, Key Biscayne, FL The Star of the Water Returns The Miami Vice filming boat is unlike any other. Built specifically for the hit TV series, the Wellcraft 38KV Scarab didn't just chase criminals on screen; it defined an era. From its cutting-edge design to its vibrant multi-colored finish referred to the Picasso of boats, it's a vessel that commands attention even today. On February 11, media members will ride this iconic boat and gain exclusive access to the stories behind this 80s symbol that reflects the visionaries who made it a cultural phenomenon. The craftsmanship and innovation poured into this vessel by the Wellcraft team, led by the legendary Don Johnson, have made the Miami Vice boat a timeless masterpiece. Meet the original Wellcraft builders and hear how this custom-built vessel became a game-changer - blending speed, style, and engineering to create a lasting legacy. An Unmatched Opportunity for Media Media professionals are invited to capture live footage, conduct interviews, and immerse their audiences in the allure of the Miami Vice era. This one-day-only event provides a chance to broadcast directly from the boat, offering an unbeatable visual backdrop of Key Biscayne's stunning waters. With its bold design and cultural significance, the Miami Vice filming boat offers endless creative possibilities for content. From exclusive behind-the-scenes insights to its enduring impact on television and boating culture, this is a story your viewers and readers will not want to miss. Ride the Legacy More than a filming prop, the Miami Vice boat became a phenomenon. It reshaped how the world viewed Miami, drawing attention to its vibrant lifestyle and helping position the city as a global hotspot. Today, it continues to inspire nostalgia and admiration. Media outlets have the rare opportunity to connect their audiences to a cultural icon that remains unmatched in style and significance, by joining this historic event. How to Reserve Your Spot This exclusive event is by invitation only and requires advanced registration. Contact Iconic Premier to secure your place and be part of this extraordinary celebration. In the event that individuals are not able to view boat on the 11th it will be in Fort Lauderdale at any time. Lights. Camera. Action. The Boat is Ready - Are You? Don't miss your chance to ride on the vessel that turned heads worldwide. Capture history, connect with legends, and share the story that made Miami Vice and Miami itself the icons of the 80s.
